NEUROONE MEDICAL TECHNOLOGIES Corp Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2019 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
NEUROONE MEDICAL TECHNOLOGIES Corp quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2019 to Q3 2024.
  • NEUROONE MEDICAL TECHNOLOGIES Corp Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $255K, a 50.8% increase year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $255K +$85.9K +50.8% Sep 30, 2024 10-K 2024-12-17
Q2 2024 $282K +$84.5K +42.8% Jun 30, 2024 10-Q 2024-08-14
Q1 2024 $111K -$114K -50.8% Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $140K -$112K -44.4% Dec 31, 2023 10-Q 2024-02-13
Q3 2023 $169K -$12.3K -6.78% Sep 30, 2023 10-K 2024-12-17
Q2 2023 $197K -$11.6K -5.55% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $225K -$11K -4.68% Mar 31, 2023 10-Q 2023-05-12
Q4 2022 $252K -$10.6K -4.03% Dec 31, 2022 10-Q 2023-02-13
Q3 2022 $181K -$108K -37.2% Sep 30, 2022 10-K 2023-12-15
Q2 2022 $209K -$32.2K -13.4% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 $236K -$19.4K -7.58% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 $263K -$6.22K -2.31% Dec 31, 2021 10-Q 2022-02-14
Q3 2021 $289K +$6.74K +2.39% Sep 30, 2021 10-K 2022-12-22
Q2 2021 $241K -$54.1K -18.3% Jun 30, 2021 10-Q 2021-08-13
Q1 2021 $255K -$52.6K -17.1% Mar 31, 2021 10-Q 2021-05-14
Q4 2020 $269K -$56.3K -17.3% Dec 31, 2020 10-Q 2021-02-16
Q3 2020 $282K Sep 30, 2020 10-K/A 2022-05-31
Q2 2020 $295K Jun 30, 2020 10-Q 2020-08-13
Q1 2020 $308K Mar 31, 2020 10-Q 2020-05-14
Q4 2019 $325K Dec 31, 2019 10-Q 2020-02-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.